Endava PLC Sponsored ADR (DAVA) Lags Q4 Earnings and Revenue Estimates

Endava PLC (DAVA) reported Q2 2025 adjusted earnings of $0.31 per share, missing the Zacks Consensus Estimate of $0.32, and revenues of $239.41 million, which fell short of expectations by 4.22% and declined from $245.3 million year-over-year. This earnings miss, coupled with a 53.5% year-to-date stock decline, an unfavorable estimate revisions trend, and the company's industry ranking in the bottom 39% of Zacks industries, has resulted in a Zacks Rank #4 (Sell), signaling potential near-term underperformance.

Analysis

Endava PLC (DAVA) reported a challenging quarter, missing consensus estimates on both the top and bottom lines. The company posted quarterly earnings of $0.31 per share, a 3.12% negative surprise against the $0.32 estimate, though this still represents year-over-year growth from $0.28 per share. More concerning is the revenue figure of $239.41 million, which not only missed forecasts by 4.22% but also marked a year-over-year decline from $245.3 million. This top-line weakness appears to be a persistent issue, as the company has now missed revenue estimates in three of the last four quarters. The market has reacted severely to this underperformance, with the stock plunging 53.5% year-to-date against the S&P 500's 9.6% gain. The negative outlook is further compounded by external analyst ratings; prior to the release, an unfavorable trend in estimate revisions had already led to a Zacks Rank #4 (Sell), signaling expectations of near-term market underperformance. The broader industry context provides an additional headwind, as the Computers - IT Services industry ranks in the bottom 39% of over 250 Zacks-ranked industries.

Key Decisions for Investors

• Investors should view the current results with significant caution, as the miss on both revenue and earnings, coupled with a year-over-year revenue decline, validates the bearish sentiment indicated by the stock's 53.5% YTD drop and its Zacks #4 (Sell) rating.
• It is critical to scrutinize management's commentary on the earnings call for any revised guidance or a credible strategic plan to address the top-line contraction, as this will be the primary catalyst for any potential change in the stock's trajectory.
• Given the recurring revenue misses and an unfavorable industry ranking, holders should reassess their positions, while prospective investors should await a clear and sustained turnaround in both revenue growth and analyst estimate revisions before considering an entry.